Modus Therapeutics AB

ABActive

Org 5566692199Sankt Eriksgatan 117, 113 43 StockholmResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2004 · 21 years old0 employees

Overview Financials People & ownership Related companies

Modus Therapeutics AB is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2004, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

Net profit 2024

SEK -577K

+79% vs 2023

Key ratios

See full ratios →

90.6%

This company

20202024

10.6×

This company

20202024

-3.5%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -9M	+1%
Net profit	SEK -577K	+79%
Total assets	SEK 16,5M	+3%
Equity	SEK 15M	-4%
Employees	0	—

Contact

Address

Sankt Eriksgatan 117, 113 43 Stockholm

john.ohd@modustx.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Modus Therapeutics AB?

Modus Therapeutics AB is registered with Bolagsverket / SCB under Org 5566692199.

Who is the CEO of Modus Therapeutics AB?

John Fredrik Öhd is the CEO of Modus Therapeutics AB, in role since 2022.

Who is the chairman of Modus Therapeutics AB?

Viktor Drvota chairs the board of Modus Therapeutics AB, in role since 2022.

Where is Modus Therapeutics AB headquartered?

Modus Therapeutics AB's registered address is Sankt Eriksgatan 117.

Modus Therapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Modus Therapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Modus Therapeutics AB